Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Lane

Showing results (131-140 of 209) with videos related to

Pageof 21
Sort By:
The American Journal of Medicine|March 1, 1985
Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndromeH C Lane, H Masur, E P Gelmann, et al.
Annals of Internal Medicine|November 15, 1990
Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluationD K Henderson, B J Fahey, M Willy, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 1, 1996
The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infectionJ D Klausner, S Makonkawkeyoon, P Akarasewi, et al.
Annals of Internal Medicine|June 11, 1990
Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trialH C Lane, V Davey, J A Kovacs, et al.
Analytical Chemistry|December 3, 2003
A comparison of microLC/electrospray ionization-MS and GC/MS for the measurement of stable isotope enrichment from a [2H2]-glucose metabolic probe in T-cell genomic DNAS D Fox, R A Lempicki, D A Hosack, et al.
Journal of Clinical Immunology|May 1, 1993
Clinical utility of an enhanced human immunodeficiency virus type 1 p24 antigen capture assayM B Vasudevachari, N P Salzman, D R Woll, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1986
Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsivenessA H Rook, J H Kehrl, L M Wakefield, et al.
Plos One|November 10, 2017
CD4+ levels control the odds of induction of humoral immune responses to tracer doses of therapeutic antibodiesSharat Srinivasula, Erin Gabriel, Insook Kim, et al.
The American Journal of Medicine|May 1, 1985
Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parametersE P Gelmann, O T Preble, R Steis, et al.
AIDS (London, England)|October 2, 2001
CD4 T cell expansions are associated with increased apoptosis rates of T lymphocytes during IL-2 cycles in HIV infected patientsI Sereti, B Herpin, J A Metcalf, et al.
Pageof 21

Showing results (131-140 of 209) with videos related to

Sort By:
Pageof 21
The American Journal of Medicine|March 1, 1985
Correlation between immunologic function and clinical subpopulations of patients with the acquired immune deficiency syndromeH C Lane, H Masur, E P Gelmann, et al.
Annals of Internal Medicine|November 15, 1990
Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluationD K Henderson, B J Fahey, M Willy, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|March 1, 1996
The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infectionJ D Klausner, S Makonkawkeyoon, P Akarasewi, et al.
Annals of Internal Medicine|June 11, 1990
Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trialH C Lane, V Davey, J A Kovacs, et al.
Analytical Chemistry|December 3, 2003
A comparison of microLC/electrospray ionization-MS and GC/MS for the measurement of stable isotope enrichment from a [2H2]-glucose metabolic probe in T-cell genomic DNAS D Fox, R A Lempicki, D A Hosack, et al.
Journal of Clinical Immunology|May 1, 1993
Clinical utility of an enhanced human immunodeficiency virus type 1 p24 antigen capture assayM B Vasudevachari, N P Salzman, D R Woll, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1986
Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsivenessA H Rook, J H Kehrl, L M Wakefield, et al.
Plos One|November 10, 2017
CD4+ levels control the odds of induction of humoral immune responses to tracer doses of therapeutic antibodiesSharat Srinivasula, Erin Gabriel, Insook Kim, et al.
The American Journal of Medicine|May 1, 1985
Human lymphoblastoid interferon treatment of Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical response and prognostic parametersE P Gelmann, O T Preble, R Steis, et al.
AIDS (London, England)|October 2, 2001
CD4 T cell expansions are associated with increased apoptosis rates of T lymphocytes during IL-2 cycles in HIV infected patientsI Sereti, B Herpin, J A Metcalf, et al.
Pageof 21